Authors Reply to Letter to the Editor - In Response to Comment on Raul E. Ruiz-Lozano et al.’s “Predictive Factors for the Prognosis of Vogt-Koyanagi-Harada Disease”

ABSTRACT

An aggressive treatment, including immunomodulatory therapy, is very important in preventing the development of the chronic recurrent stage in Vogt-Koyanagı-Harada (VKH) disease. However, the way of treatment is not the only factor determining the prognosis, and there are other factors that affect the outcome.

KEYWORDS:

• Predictive factor
• prognosis
• uveitis
• uveitis treatment
• Vogt-Koyanagi-Harada disease

Disclosure statement

No potential conflict of interest was reported by the author(s).

Additional information

Funding

The author(s) reported there is no funding associated with the work featured in this article.